PP-TZ
SKU: PP-TZ
PEPPU-coded dual-incretin catalog material for receptor pharmacology and metabolic-pathway assay design.
For research purposes only.
First batch certificate of analysis: PP-TZ-60-01
Janoshik sterility test report #196436 for PP-TZ-60 batch PP-TZ-60-01: TAMC pass and TYMC pass. Analysis conducted 2026-07-07. Verification key 8G5DWDUBFR8B.
Janoshik task number: #196436
Sample: PP-TZ-60
Manufacturer: Peppu Labs
Testing ordered: 2026-06-13
Sample received: 2026-06-16
Analysis conducted: 2026-07-07
Tests requested: Sterility testing (TAMC+TYMC)
Unique verification key: 8G5DWDUBFR8B
Results: TAMC: PASS; TYMC: PASS
Verify this test on JanoshikView the report imageFirst batch certificate of analysis: PP-TZ-30-01
Janoshik sterility test report #196435 for PP-TZ-30 batch PP-TZ-30-01: TAMC pass and TYMC pass. Analysis conducted 2026-06-30. Verification key TYXLDIHW65ST.
Janoshik task number: #196435
Sample: PP-TZ-30
Manufacturer: Peppu Studio
Testing ordered: 2026-06-08
Sample received: 2026-06-16
Analysis conducted: 2026-06-30
Tests requested: Sterility testing (TAMC+TYMC)
Unique verification key: TYXLDIHW65ST
Results: TAMC: PASS; TYMC: PASS
Verify this test on JanoshikView the report imageFirst batch certificate of analysis: PP-TIRZ-20-01
Janoshik task #164752 for PP-TIRZ-20 batch PP-TIRZ-20-01: Tirzepatide 21.93 mg and purity 99.676%. Analysis conducted 2026-05-26. Verification key QLCJIC3GSNRN.
Janoshik task number: #164752
Sample: PP-TIRZ-20
Manufacturer: Peppu Labs
Testing ordered: 2026-05-16
Sample received: 2026-05-21
Analysis conducted: 2026-05-26
Tests requested: Common GLP-1 peptide blind test (Semaglutide, Tirzepatide and Retatrutide)
Unique verification key: QLCJIC3GSNRN
Results: Tirzepatide: 21.93 mg; Purity: 99.676%
Verify this test on JanoshikView the report image
